1. Home
  2. AOUT vs CHRS Comparison

AOUT vs CHRS Comparison

Compare AOUT & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Outdoor Brands Inc.

AOUT

American Outdoor Brands Inc.

N/A

Current Price

$15.31

Market Cap

152.9M

Sector

Industrials

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$1.33

Market Cap

177.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AOUT
CHRS
Founded
2020
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
177.7M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
AOUT
CHRS
Price
$15.31
$1.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$12.50
$5.51
AVG Volume (30 Days)
308.7K
1.0M
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
472.00
EPS
N/A
N/A
Revenue
$190,536,000.00
N/A
Revenue This Year
N/A
$73.08
Revenue Next Year
$8.06
$30.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.26
$1.09
52 Week High
$16.09
$2.62

Technical Indicators

Market Signals
Indicator
AOUT
CHRS
Relative Strength Index (RSI) 68.09 47.50
Support Level $8.04 $1.31
Resistance Level $16.09 $1.51
Average True Range (ATR) 0.79 0.07
MACD 0.52 0.00
Stochastic Oscillator 83.52 19.44

Price Performance

Historical Comparison
AOUT
CHRS

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: